Lamb, Justin; Ramaswamy, Sridhar; Ford, Heide L et al. (2003) A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell 114:323-34
|
Fournier, Marcia V; Martin, Katherine J; Graner, Edgard et al. (2003) Sensitive assays for detection of lung cancer. Molecular markers in blood samples. Methods Mol Med 75:239-50
|
Sotiropoulou, Georgia; Kono, Mari; Anisowicz, Anthony et al. (2002) Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer. Mol Med 8:42-55
|
Biswas, D K; Cruz, A; Pettit, N et al. (2001) A therapeutic target for hormone-independent estrogen receptor-positive breast cancers. Mol Med 7:59-67
|
Martin, K J; Graner, E; Li, Y et al. (2001) High-sensitivity array analysis of gene expression for the early detection of disseminated breast tumor cells in peripheral blood. Proc Natl Acad Sci U S A 98:2646-51
|
Fournier, M V; Martin, K J; Pardee, A B (2001) Solid tumor cancer markers and applications to steroid hormone research. Methods Mol Biol 176:329-40
|
Guan, R J; Ford, H L; Fu, Y et al. (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60:749-55
|
Huang, L; Pardee, A B (2000) Suberoylanilide hydroxamic acid as a potential therapeutic agent for human breast cancer treatment. Mol Med 6:849-66
|
McGowen, R; Biliran Jr, H; Sager, R et al. (2000) The surface of prostate carcinoma DU145 cells mediates the inhibition of urokinase-type plasminogen activator by maspin. Cancer Res 60:4771-8
|
Biswas, D K; Cruz, A P; Gansberger, E et al. (2000) Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Proc Natl Acad Sci U S A 97:8542-7
|
Showing the most recent 10 out of 35 publications